<SEC-DOCUMENT>0001213900-18-003527.txt : 20180327
<SEC-HEADER>0001213900-18-003527.hdr.sgml : 20180327
<ACCEPTANCE-DATETIME>20180327164918
ACCESSION NUMBER:		0001213900-18-003527
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20180327
DATE AS OF CHANGE:		20180327

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOSCIENCE, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-220351
		FILM NUMBER:		18715991

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>f424b5032618_aytubioscience.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><B><BR>
<BR>
Filed pursuant to Rule 424(b)(5)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><B>Registration No.&nbsp;333-220351</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; background-color: white"><B>Prospectus Supplement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>(To Prospectus dated October 24, 2017)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="https:||www.sec.gov|Archives|edgar|data|1385818|000114420417053943|aytu_logo.jpg" STYLE="height: 63px; width: 189px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">9,844,684 Shares of Common Stock Offered by
Selling Stockholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 13.5pt 0 0; background-color: white">This prospectus supplement (&ldquo;Supplement&rdquo;)
modifies, supersedes and supplements information contained in, and should be read in conjunction with, that certain prospectus,
dated October 24, 2017, of Aytu BioScience, Inc. (the &ldquo;Original Prospectus&rdquo;). This Supplement is not complete without,
and may not be delivered or used except in connection with, the Original Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; background-color: white"><B>See &ldquo;Risk Factors&rdquo;
beginning on page 7 of the prospectus dated October 24, 2017, for risk factors and information you should consider before you purchase
shares.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 9pt 0 0; background-color: white">On March 23, 2018, the Company
entered into a warrant exercise agreement (the &ldquo;Exercise Agreement&rdquo;) with Armistice Capital Master Fund Ltd.
(&ldquo;Armistice&rdquo;). Pursuant to the Exercise Agreement, the Company agreed to reduce the exercise price of
Armistice&rsquo;s warrants to purchase 1,500,000 shares of common stock (the resale of the underlying shares of which were
included in the Original Prospectus (the &ldquo;Original Warrants&rdquo;)) from $3.60 to one cent less than the closing price
on the last trading day prior to the exercise date, ($0.41 per share) and Armistice agreed to exercise the Original
Warrants for cash by March 23, 2018. The Company also agreed to issue to Armistice new warrants to purchase 2,000,000 shares
of the Company&rsquo;s common stock at an exercise price of $0.54 per share. In accordance with the Exercise Agreement,
Armistice exercised the Original Warrants for an aggregate exercise price of $615,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>The date
of this prospectus supplement is March 27, 2018.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 3pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ /P"] P$1  (1 0,1 ?_$ ,$   $#! ,!
M      D " H"!@<+ P0% 0$!   & P$               $" P<("00%"@80
M   % P," P4#!@(;      $" P0%$08' !(((0DQ$PI!46$B%'$R%8%"(Q87
M&958D:&QT5)STR0T9+34)76U)G:V-U=WEQ@X*3D:$0 ! P(% P("!0D)
M   !  (#$00A$@4&!S%!"%$382)QD;$R%(&AP>%28B,5"?!"TC-STR24%O_:
M  P# 0 "$0,1 #\ GN>;L+L ACK")J)E'Y@"G01J/@;4[I8X9FP'H[O]*XM;
M%MRVSMSF;)@_&M!UJ@+=Q_FG>$)D-EBS$5T+0J5H$!Q=4G'B0RBDZZ*)$&H*
M&W%I&E&IR^P=9*\1<5OFMG:YJ$;Q:3--1B*L/<&N%?5:BO-?RJU2VY '&^TF
MA^FZ-EFDD C>'R@%I:":/&3HX' DH<R/,CDP7;Y65;A1(4-BBJ@MA"@>(B D
M'J--7S?P_L+<-TS26R&-SFA[JROP [&F/=84V_E7S1HSG:]975H YQC8TVL;
MB&DU -<"<.JQI>W<9S=9ZBB),N3KZ2#Y5VZ!4%2@)Q I17$"_HQ$==/K7&>R
MM-O&:'9/+K6UH'O]QY'RFI&./1?9;1Y@YNUN27<\U[:,O+RI##:L%<_< '+0
M]@B(=O?D[G:5NA/(.:;TE9FW;H,5C$P+D$1+'1RI@(B_-M OZ,3%K4?;K3#Y
MC>5FTN/>?--XZV_+%)MYKBV20.:X-+G,S$N<W/@:_11>@7P]\=]Z7'#%IR+N
MELAW'JEF97_(Y@(:YPCHP'(*M';K7%2.(U5%XT0?ME"*IN42+(BD81*=-0 ,
M0Q>M! 2" ZR5]RRW(RVO+5XDTX-SM>TFCPYH(H</I7T3M-_EVISYZM<YU"#V
M(Z_G7MH"44P$H" 5-T$:C6O77*L;UM_;^^UI:W,6T/[II^A2&,1'*,0N;7,4
M%Y[^18QQ04D'C1@@.T/.>N$&R)S"(@"8*+'( &]NB+@CY6/D1/\ 1/V3O9]Y
M-F];O2EH%0W';F."8B'6@]1^S1%ZA.H;J4W>SW4KTT15Z(EHB6B):(EHB6B)
M:(EHB6B):(EHB6B):(FA<L\\QF ,07#>IW*99]R@YB[6:B>AWDVLF8B )!XF
M!$1 P_#7UW'FW7;VUB-D3286$EQ[ -P(- <3V5@_(?E;;'"O&6I;FGG:-5N(
M'PVH+V9G3Y<,H<YI.6M7!IJH>F0\B-!E96Z;TEE32<X\<R;]85R+N7KYZJ==
MPBH503&(4#GVE$>NT #6P[1KZUT[16:#$UHG:S** ?8,?S+SH?B-Q;X=<7>5
M\^X+NXD<Y[\SB6/)(Q)+NIPQ(HFFWKFF6DC'9P!$XR/.8R8$ZJK+D$:%4%4!
M 2F.7W#XZ^=U*YTK37C+.6:E*,@^< @N[4P(Q5R=L\;60:PZFR:4P@.D )RA
MS?O4!%!WZKY@C&LCE?(\=#+H**Q97))B=?+%.)4TDS@<J"JYZB8IA+X"(ZQ<
M\L^9MK>/'$%]<ZU=4W3JL3VVQ,K ?<<TL% ]S'G$_P!TDU6Q+PH\=8>?>7+&
MST^WN3M7396/N@*T$;7!QQ8Q[&X=<P 1]<=LV\8*T>T;)LVC"/19L?(  (F5
MN%$P I0  *82UI\=>0KER^U?7[:\W7K$TDFK^\U\;W.<74+ZNQ<2[IZ%>MO5
M]%T3:^T+';VW8V,TR*$1Q!H;@P4 !RAH)]:"E:HTW$O+2MY6FM:<FN!IVW4T
MD6XB8=SMF-!*H0!&H@D4P%Z>[6W/PH\A[+>_#^G[8O)"_=5J'0FKFEQ ?1I(
M+W//RTQ*UV\^<>7FW-2_F4#2+2Y)=4 T![BM  3Z)[#4P&1*(?$!^T!H/\O6
MPL1-B 8UH;@#0"F)ZJPK8G0-$;S5P"2YQ( #4"  '.)SB!42@0AC55/^:0M*
MCHHK64^IC[PN2>0',%MQ2XN9%NR#QG@)XY@)YU84S*1[F^,H*JE)+)&5A%TG
M,A'0XD(D@4AC;UA,%.FB)O'I[N\IE#B/S9A<?<DLI7K=.#\\O&5@7.XO:X96
M8_4.['[HK:W[G2_%E5Q8MP?F!NY)\HE(;KX:(MJ,M*L4HP\PFY!>-*P_&/JF
M2I%VR[(42N#/&ZQ1,55N"(;B[:[@&H:(A97+WR.UA:4W,VW<G,G%L%.VW).X
MN>A9.0=,9J,D&*HHNFSE@Y:)J[4E H- ZTZ5T1$/PEG+$_(FPHG*>%;^M[).
M/[A2*M$W/;$DVDHIS0/G3(9$PJ(+$K\Q%  P>[1%E=80#883B6AA#;NH"@F*
M(;1"@F,/M  H-=$3'>3'<AX1<-[@A[2Y*\CL<8JNB>9&D8V$N.92:2BS(H@
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MHB%1^W1%#F]:.4$^WMQ^V!MIR;9 %!'H!K*N0Q@J/O$-$6!/1+")\#<P -U
MF2K5 H>P - E,/3VU$=$4Y<2E'I0.OPT10:O6V% , \,:!2F7+J*'V?JF\Z:
M(KK]$_\ ]J7*W_C;%?ZIQFB*;7HB _ZE#_U <J/\0Q?^5&VB+3\%_L1?^FM/
M[A>:(M]3<-LQET6[-VO<[5*8A+ABWT5,LW"9#MW3)\B=NX052-4IBG14$/#I
MXAUZZE??MMM2B;9#(<PK3]?JN!?:?8ZU*_3KF,2:+*T QDFA/?'!V)^*UMW<
MHX.3W#_EQ<.)HV-.>TKYFW%Q8G>'\T$'EMS3HRB30B@5*"\.NH=':(B(4)7Q
MUDDWDW1M*VW&^< 3!M#BZH-,1@"%A7K'%^OW'+\7%FWBX6NJ3Q-@:,M +AV4
M8N=VI3YGCXT3HL#-9'!MJPT-;LH=,PG!U.%,N7RWCM0@"NDJ4X& 2"J(@'A3
MV:T5<[;H_P#?;_U36]6O'SW0EFMXB6?<MA(\LB% T$-K0$C-ZE>J_P ?/$O:
MG$/%^D[7T>SC@O&VT$UTYI=6:]$3&S3FLKP'/<VI#3D'8)_]@YY@9DJ+&XTT
M866,&PCD5BA&G'P IC&&OF&]P:PIUW8]@+K\5ITQCN ?E(83]I5Q-U;!UFWC
M<R"0F$@DFC</R9L4\_$,2YO"Y&D-#D,]6E#MDD5FP@H0B+E0"'<?+7HB6H]>
MFK8[UVOJV^M8T?8FEL<^\D?DN'B@,KR]I8X@D-%&U'RFGJL>N0YF[5VPZZ,V
M2>-IS.( )(Q!IB I &-[0B<=VI%VS'EV)L6H?4J"!A,Y<" *.UO$PB=18X^V
MGNUZ%>(^+]&XFXKL-IZ' RV9% QTH:2<TCL7$U<[N:8&BU,;YW:_7=:DO-1<
M7OE<:5[-'3H%$=]6+W3T<"8-8\"<17 +?)^;XL93*[B*<@61M7&BA@^FC16(
MJ"K=_<2P4$H"!A0^W5TVL9&T-8*-H/UKY:'VO;'LC*ST0#>P/Z?.W.YWCW(.
M?>1LU>-AX?CY!.V<>N+8221=W1.- (68<%^I*.YBRW$ IRB(&/NU%55(M#T:
MW;[.'7*^9Q M2E$7,>)A !&N^I0H;=7IHB^&]&MV_$Z&+E;,F[< $!1RP\HZ
M@U "K$ .I #J'4.NB*,KZ@'L01O:P1QAE?!,M=U[X&OE)>VKCEKA;%6=VG>#
M<?.;(NET (#=I+)[O*$: -*:(BU>D9[KA6BLGVU\T71Y"3D'US<=I&6=E(8[
MS:=U<=A-U7)AH8Y#?4,TJB%2'  ]FB*3YW[0_P##GS_-\OG-\$2IB"4P%*6D
MQ#%H6GWJ;A Q1Z;M$6O_ /2;FW=V:QRCU ,<WK0.G04VI3%\  :@(Z(ML*1(
MA#G,4M#*&.<XU'YC?*6HU&G0I0#1%RFI0:]0Z?S=$4.3UI77M[\?ZU  Y-,:
MT_T)N0 _+HBP#Z)3_81S"\*?M*M/IN"M?P OL\:4T13F35H-*B-.E*5_)40#
M1%")]:[;4J\XP<0[I305<0\1FV?823Q(AO(9FD;2?_2G<'(4] ,=(2A[Q'PT
M1!2]/KWUN-/:;PEF;&V:;"R'>$ODC([.[8Q[92#!=!O&MX!I';' R#EH)3BN
M@(C0!&GAHBD&_P#V>\ !Z?L7SOU_M&#_ +]T1#>[L/J>N'?._@MF7C)CO%V6
M8.\,C,FT?$R%Q-(DL0U*BN1;SGBJ+_>40$@#0 'KHB@YH6Y)K6A)W2BQ.> C
MKE@K=D):H>4WE9J*N)[#L=N_:#AY'P#Y38)JB"%0\!T1;[0I#*%'SBB!AKT
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M$1.F% ,8!I[.NB(V)% $^T# /0XA4!W&Z@(B4>@;"UIHBY%*[?EI41  J B
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95DV_X[^-&@B*)$ ZX!Y9=Q0$W4-/G1?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
